Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Permissive Cardiotoxicity As a Guiding Principle to CAR-T Therapy with Reduced Ejection Fraction Heart Failure

Forat Lutfi, Briha Ansari, Afraah Hawa, Al-Ola Abdallah, Zubair Shah, Andre Khazak, Hussam Hawamdeh, Marc S. Hoffmann, Muhammad Umair Mushtaq, William Wesson, Aliya Rashid, Maggie Nelson, Leyla Shune, Sunil Abhyankar, Joseph P McGuirk, Charles Porter, Nausheen Ahmed

Blood (2023) 142 (Supplement 1): 6916.

https://doi.org/10.1182/blood-2023-188031

Published: 2023

Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Joe S. Al-Ramahi, Moazzam Shahzad, Muhammad Kashif Amin, Shaun DeJarnette, Maggie Nelson, Forat Lutfi, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq

Blood (2023) 142 (Supplement 1): 7028.

https://doi.org/10.1182/blood-2023-185209

Published: 2023

Journal Articles

131 I-Apamistamab Effectively Achieved Durable Responses in Patients with R/R AML Irrespective of the Presence of Multiple High-Risk Factors

Blood (2023) 142 (Supplement 1): 2159.

https://doi.org/10.1182/blood-2023-187433

Published: 2023

Journal Articles

Comparison of Biosimilar Filgrastim (Nivestym) Versus Originator Filgrastim (Neupogen) for Peripheral Blood Stem Cell Mobilization for Allogeneic Hematopoietic Stem Cell Transplantation

Moazzam Shahzad, Joe S. Al-Ramahi, Muhammad Kashif Amin, Muhammad Fareed Khalid, Shaun DeJarnette, Zahra Mahmoudjafari, Maggie Nelson, Riley Hastings, Haitham Abdelhakim, Forat Lutfi, Nausheen Ahmed, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq

Blood (2023) 142 (Supplement 1): 3523.

https://doi.org/10.1182/blood-2023-185652

Published: 2023

Journal Articles

High-Dose Targeted Radiation with 131 I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML

Blood (2023) 142 (Supplement 1): 3529.

https://doi.org/10.1182/blood-2023-189040

Published: 2023

Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Joe S. Al-Ramahi, Shaun DeJarnette, Forat Lutfi, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq

Blood (2023) 142 (Supplement 1): 2242.

https://doi.org/10.1182/blood-2023-182521

Published: 2023

Journal Articles

131 I-Apamistamab-Led Allogeneic Hematopoietic Cell Transplant Significantly Improves Overall Survival in Patients with TP53 Mutated R/R AML

Blood (2023) 142 (Supplement 1): 469.

https://doi.org/10.1182/blood-2023-182177

Published: 2023

Journal Articles

Inb-100: A Pilot Study of Donor Derived, Ex-Vivo Expanded/Activated Gamma-Delta T Cell (EAGD) Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide (PTCy)

Joseph P McGuirk, Sunil Abhyankar, Trishna Goswami, Halie Juarez, Mariska ter Haak, Tyce Bruns, Samantha Youngblood, Lawrence S. Lamb

Blood (2023) 142 (Supplement 1): 4853.

https://doi.org/10.1182/blood-2023-181184

Published: 2023

Journal Articles

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Blood (2021) 138 (22): 2278–2289.

https://doi.org/10.1182/blood.2021012021

Published: 2021

Includes: Supplemental data

Journal Articles

Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Muhammad Salman Faisal, Ezza Tariq, Ali Hussain, Muhammad Arslan, Venkata Thammineni, Leena Syed, Alvina Karam, Iqra Anwar, Sibgha Gull Chaudhary, Nausheen Ahmed, Tara L. Lin, Sunil Abhyankar, Peiman Hematti, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 3961.

https://doi.org/10.1182/blood-2021-152122

Published: 2021

Journal Articles

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

Blood (2021) 138 (Supplement 1): 1791.

https://doi.org/10.1182/blood-2021-148497

Published: 2021

Journal Articles

Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Muhammad Umair Mushtaq, Moazzam Shahzad, Muhammad Usman Zafar, Muhammad Arslan, Ezza Tariq, Naira Fatima, Syeda Sadia Bokhari, Javeria Shahani, Iqra Anwar, Sibgha Gull Chaudhary, Anurag K. Singh, Sunil Abhyankar, Natalie S. Callander, Peiman Hematti, Joseph P. McGuirk

Blood (2021) 138 (Supplement 1): 1848.

https://doi.org/10.1182/blood-2021-145632

Published: 2021

Journal Articles

Outcomes with Natural Killer Cells Infusion after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Muhammad Umair Mushtaq, Moazzam Shahzad, Amna Y Shah, Muhammad Usman Zafar, Ezza Tariq, Anam Hamid, Ayna Serwat, Iqra Anwar, Sibgha Gull Chaudhary, Nausheen Ahmed, Sunil Abhyankar, Natalie S. Callander, Peiman Hematti, Joseph P. McGuirk

Blood (2021) 138 (Supplement 1): 1847.

https://doi.org/10.1182/blood-2021-146696

Published: 2021

Journal Articles

Outcomes with "Off the Shelf" Allogeneic CD19 Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies: A Systematic Review and Meta-Analysis

Muhammad Umair Mushtaq, Moazzam Shahzad, Ali Hussain, Amna Y Shah, Raheel S Siddiqui, Muhammad Salman Faisal, Iqra Anwar, Sibgha Gull Chaudhary, Ghulam Rehman Mohyuddin, Ramesh Balusu, Aung M Tun, Rajat Bansal, Haitham Abdelhakim, Marc Hoffmann, Anurag K. Singh, Leyla Shune, Sunil Abhyankar, Joseph P. McGuirk, Nausheen Ahmed

Blood (2021) 138 (Supplement 1): 4831.

https://doi.org/10.1182/blood-2021-148999

Published: 2021

Journal Articles

Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Sibgha Gull Chaudhary, Ali Hussain, Fatima Ali, Ayesha Khalid, Ezza Tariq, Muhammad Usman Zafar, Muhammad Arslan, Iqra Anwar, Rajat Bansal, Peiman Hematti, Tara L. Lin, Sunil Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 4825.

https://doi.org/10.1182/blood-2021-145666

Published: 2021

Journal Articles

Outcomes with Venetoclax in Relapsed Acute Myeloid Leukemia after Allogenic Hematopoietic Stem Cell Transplantation: A Systemic Review and Meta-Analysis

Pranali Santhoshini Pachika, Moazzam Shahzad, Razwana Khanam, Adeel Masood, Zahoor Ahmed, S Fatima Ali, Asmi Chattaraj, Muhammad Tahir, Faiz Anwer, Ramesh Balusu, Sibgha Gull Chaudhary, Sunil Abhyankar, Nausheen Ahmed, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 4410.

https://doi.org/10.1182/blood-2021-145492

Published: 2021

Journal Articles

Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation over the Last 15 Years: A Systematic Review

Muhammad Umair Mushtaq, Moazzam Shahzad, Ezza Tariq, Muhammad Arslan, Sara Shahid, Raza Ur Rahman, Faryal Murtaza, Iqra Anwar, Qamar Iqbal, Sibgha Gull Chaudhary, Ramesh Balusu, Nausheen Ahmed, Peiman Hematti, Sunil Abhyankar, Joseph P. McGuirk, Leyla Shune

Blood (2021) 138 (Supplement 1): 4910.

https://doi.org/10.1182/blood-2021-146218

Published: 2021

Journal Articles

Outcomes with Interferon in Polycythemia Vera: A Systematic Review and Meta-Analysis

Moazzam Shahzad, Mamoon Ahmed, Muhammad Arslan, Sakina Abbas, Tooba Kashif, Iqra Anwar, Muhammad Salman Faisal, Muhammad Usman Zafar, Sibgha Gull Chaudhary, Leyla Shune, Sunil Abhyankar, Joseph P. McGuirk, Abdulraheem Yacoub, Muhammad Umair Mushtaq

Blood (2021) 138 (Supplement 1): 3659.

https://doi.org/10.1182/blood-2021-145807

Published: 2021

Journal Articles

First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide

Lawrence S. Lamb, Jr., PhD, Melissa Jo Beelen, Mjbeelen@incysus.com, Samantha Langford Youngblood, BS, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-142876

Published: 2020

NARROW

Permissive Cardiotoxicity As a Guiding Principle to CAR-T Therapy with Reduced Ejection Fraction Heart Failure

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

131 I-Apamistamab Effectively Achieved Durable Responses in Patients with R/R AML Irrespective of the Presence of Multiple High-Risk Factors

Comparison of Biosimilar Filgrastim (Nivestym) Versus Originator Filgrastim (Neupogen) for Peripheral Blood Stem Cell Mobilization for Allogeneic Hematopoietic Stem Cell Transplantation

High-Dose Targeted Radiation with 131 I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML

Outcomes after Bone Marrow Versus Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

131 I-Apamistamab-Led Allogeneic Hematopoietic Cell Transplant Significantly Improves Overall Survival in Patients with TP53 Mutated R/R AML

Inb-100: A Pilot Study of Donor Derived, Ex-Vivo Expanded/Activated Gamma-Delta T Cell (EAGD) Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide (PTCy)

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine ( 131 I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Outcomes with Natural Killer Cells Infusion after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Outcomes with "Off the Shelf" Allogeneic CD19 Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies: A Systematic Review and Meta-Analysis

Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Outcomes with Venetoclax in Relapsed Acute Myeloid Leukemia after Allogenic Hematopoietic Stem Cell Transplantation: A Systemic Review and Meta-Analysis

Top 100 Cited Articles on Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis

Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation over the Last 15 Years: A Systematic Review

Outcomes with Interferon in Polycythemia Vera: A Systematic Review and Meta-Analysis

First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only